From Name:
From Email:
To Name:
To Email:

Optional Message:


Brintellix (vortioxetine) renamed Trintellix (vortioxetine) in US to avoid name confusion

from Takeda Pharmaceuticals

Takeda Pharmaceuticals, a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, and Lundbeck announced that Brintellix (vortioxetine) will be marketed in the United States under the new name Trintellix (vortioxetine) starting in June of 2016. The vortioxetine product is a prescription medicine approved to treat Major Depressive Disorder (MDD) in adults. The formulation, indication and dosages of Trintellix remain the same as that of Brintellix. Click here to see the full press release. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063